As for the risk of developing the MS, the respective multivariate-adjusted hazard ratios of developing the MS were 1.0 (referent), 1.43 (95% CI, 1.14-1.79), 1.14 (95% CI, 0.91-1.44), 1.45 (95% CI, 1.14-1.84), and 1.59 (95% CI, 1.24-2.05) (P for trend for current smokers only =0.001). Among men without the MS at entry, body weight gain over 7 yr, compared with never smokers, was significantly higher in smokers who quit smoking. It is important for the prevention of the MS not only to quit smoking but also to prevent weight gain after smoking cessation.
Introduction
Smoking is a major risk factor for coronary heart disease (CHD), with a dose-response correlation between CHD morbidity and mortality and the number of cigarettes smoked 1) . Several studies have shown that smoking induces insulin resistance or hyperinsulinemia and leads to type 2 diabetes [2] [3] [4] [5] . Increased insulin resistance may underlie the clustering of the metabolic and hemodynamic abnormalities that have potent atheroslerotic properties, designated metabolic syndrome (MS) 6, 7) . Thus, the MS may account for the observed link between smoking and atherosclerotic disorders 8) . The Adult Treatment Panel III of the National Cholesterol Education Program (NCEP) recently proposed a definition of the MS to aid identification of individuals at risk for both CHD and type 2 diabetes 9) . The definition incorporates thresholds for five easily measured variables linked to insulin resistance: waist circumference, triglyceride level, highdensity lipoprotein (HDL) cholesterol level, fasting plasma glucose level, and blood pressure. To the best of our knowledge, however, no studies have examined the association between cigarette smoking and the MS defined by the NCEP criteria. Using a modified NCEP criteria with body mass index (BMI) instead of waist circumference, we examined the association of cigarette smoking with the prevalence of the MS in Japanese male office workers, and performed a longitudinal study to prospectively examine the association of cigarette smoking with the development of the MS.
Methods

Subjects and study design
The study was conducted among employees of Company A, one of the largest building contractors in Japan. A total of 3,649 Japanese male office workers aged 35-59 yr with no prior history of CHD or stroke participated in cardiovascular risk surveys in May 1994. All the participants were white-collar workers, and most were professionals. This study was conducted in accordance with the principles set out in the Declaration of Helsinki 1975, as revised in 1993. The study design was approved by the ethical committee of the Japan Labor and Welfare Association. Only the field data set, which excluded the private information such as name and insurance number, was uses for the study. All participants were informed of the nature of the screening and all signed the questionnaire.
Of 3,694 potential participants, 586 (16.1%) were identified to have the MS at the initial examination. The remaining 3,063 men constituted the MS-free cohort, and were re-examined over 7 successive years until May 2001. We also excluded 69 men who did not participate in consecutive annual health examinations during the followup. The final study cohort for analysis therefore consisted of 2,994 men. Men in whom the MS was found during repeated surveys through May 2001 were defined as incidental cases of the MS.
Annual health examinations at study entry included medical history, physical examination, a questionnaire on health-related behavior, anthropometric measurements, and biochemical measurements. The participants were asked to fast for at least 8 h and to avoid heavy physical activity for more than 2 h before the examinations. Medical history and use of prescription drugs were assessed by the examining physicians. A family history of diabetes was defined as having a mother, father, sister, or brother with diagnosed diabetes. As for health-related behavior, data on smoking status, alcohol intake, and regular physical activity were obtained by interview. The questionnaire asked about smoking habits (never, past, or current smoker); past or current smokers were asked about the number of cigarettes smoked per day and the duration of smoking in years. Current smokers were subdivided into three groups by the daily number of cigarettes smoked: 1-20 cigarettes/d, [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] cigarettes/d, and ≥31 cigarettes/d. The questions about alcohol intake included items about the type of alcoholic beverage, the frequency on a weekly basis of alcohol consumption, and the usual amount consumed daily. Weekly alcohol intake was calculated and then converted to daily alcohol consumption (grams of ethanol per day) by using standard Japanese tables. Participants were asked about the type and frequency on weekly basis of leisure-time physical activity. Physical exercise was defined as participation in any physical activity, such as jogging, cycling, swimming or tennis, that was performed long enough to cause sweating. BMI, calculated as weight divided by the square of height in meters, was used as an index of relative weight. After a 5-min rest in a quiet room, systolic and diastolic blood pressures were measured on the right arm by using a standard mercury sphygmomanometer. Blood samples were drawn from an antecubital vein. Serum HDL cholesterol level and triglyceride level and fasting plasma glucose level were determined according to standard laboratory procedures 10, 11) . The five variables of the MS (blood pressure, BMI, HDL cholesterol, triglycerides, and fasting glucose) were measured at annual health examinations in May from 1995 to 2001. Quality control of the laboratory was internal, and the coefficients of variation within assays for serum triglycerides and HDL cholesterol and plasma glucose were no more than 3% between 1994 and 2001. Data on smoking status were also obtained by interview at annual health examinations from 1995 to 2001.
The five thresholds used were BMI ≥25, proposed by the Japan Society for the Study of Obesity 12) , systolic blood pressure ≥130 mm Hg and/or diastolic blood pressure ≥85 mm Hg, triglyceride level ≥1.69 mmol/l, HDL cholesterol level <1.03 (men) and <1.29 (women) mmol/l, and fasting glucose level ≥6.1 mmol/l 9) . Individuals met the criteria for high blood pressure or high fasting glucose level if they were currently using blood pressure medications or hypoglycemic diabetes control. Individuals were classified as having the MS if they fulfilled three or more of the criteria.
Statistical analyses
The chi-square test and unpaired t test were used to analyze the statistical differences among characteristics of the study participants at enrollment in relation to the MS. Logistic regression was used to estimate the odds of the MS in each smoking category. For each participant, person-years of follow-up were calculated from the date of enrollment to the date of the first incidence of the development of the MS or the date of the last follow-up, whichever came first. Cox's proportional hazards models were used to evaluate the association between smoking status and development of the MS. To examine the association of cigarette smoking with body weight trend over a 7-yr period, we used a simple linear regression model. Each individual's eight body weight values were regressed on the time of survey. The slope coefficient of this model was used to represent an individual's body weight trend. Differences in mean values of body weight change over 7 yr among categories of smoking status were tested by a generalized linear model analysis. Logistic regression was used to estimate the odds of body weight gain of ≥5 kg at study end in each smoking category. In the multivariate analyses, data were adjusted for age, family history of diabetes, alcohol intake, and physical activity at study entry. Potential confounding factors, except for age, were treated as categorical variables: family history of diabetes (no or yes); alcohol consumption (graded as 1 [ Data were analyzed by using the SPSS/PC statistical package (SPSS, Chicago, IL). All reported P values are two-tailed, and those less than 0.05 were considered to be statistically significant.
Results
As defined by the modified NCEP criteria, 586 men (16.1%) had the MS at baseline assessment. The characteristics of those with and those without the syndrome are shown in Table 1 . Mean age and the percentage of participants with a family history of diabetes were significantly higher in those with the MS than those without. The percentages of those who never smoked and smoked ≥31 cigarettes/d were lower and higher in those with the MS than those without, respectively. Table 2 shows the risk of prevalence of the MS in relation to smoking status. With adjustment for age, family history of diabetes, alcohol intake, and regular physical activity, Table 3 shows the risk of developing the MS during 7 yr of follow-up in relation to smoking status at study entry. With adjustment for age, family history of diabetes, alcohol intake, and regular physical activity, the hazard ratios of developing the MS, compared with never smokers, were 1.43 (95% CI, 1.14-1.79) for ever-smokers, 1.14 (95% CI, 0.91-1.44) for those who smoked 1-20 cigarettes/d, 1.45 (95% CI, 1.14-1.84) for those who smoked 21-30 cigarettes/ d, and 1.59 (95% CI, 1.24-2.05) for those who smoked ≥31 cigarettes/d (P for trend for current smokers only=0.001). Table 4 shows body weight change between 1994 and 2001 among men without the MS at entry in relation to smoking status during the follow-up period. Significance in comparison with never smokers who never smoked was found in smokers who quit smoking for an increase in body weight and a slope of body weight over 7 yr. The multivariateadjusted odds ratio for a weight gain of ≥5 kg, compared with never smokers who never smoked, was 2.45 (95% CI, 1.57-3.82) for smokers who quit smoking.
Discussion
We found a positive and dose-response relationship between the daily number of cigarettes smoked and the risk of the MS in both cross-sectional and longitudinal analyses. A slightly stronger association was observed in longitudinal analyses, and the risk of developing the MS was significant among those who smoked 21-30 cigarettes/d. Ex-smoking was also associated with a higher risk of the MS. With adjustment for potential risk factors associated with the MS, most of the association between smoking status and the risk CI indicates confidence interval. *The test for trend is calculated across increasing categories of smoking for current smokers only. † Adjusted for age, family history of diabetes, alcohol intake, and regular physical activity at study entry.
of the MS did not change. Analyses of body weight change according to smoking status during the follow-up period revealed that body weight gain was significantly higher in smokers who quit smoking than in never smokers. These results indicate that cigarette smoking is associated with an increased risk of the MS and that smoking cessation is also associated with the risk of the MS owing to subsequent body weight gain. To prevent the MS, we need not only to encourage smoking cessation but also to concomitantly help patients prevent weight gain after smoking cessation.
Although many pharmacological actions of cigarette smoking and nicotine have been demonstrated 13) , the mechanism of how cigarette smoking increases the risk of the metabolic aberrations is still not clear. A negative effect of cigarette smoking on insulin sensitivity has been documented in several studies [2] [3] [4] . Cigarette smoking increases the circulating levels of insulin-antagonistic hormones (i.e., catecholamines, cortisol, and growth hormone) [14] [15] [16] . An additional negative factor for the insulinmediated glucose uptake is high circulating levels of free fatty acids, indicating increased lipolysis 17) . Thus, cigarette smoking may provoke the metabolic perturbations and may increase the risk of the MS.
As for mechanism of weight gain after smoking cessation, mechanisms of weight gain may include increased energy intake, decreased resting metabolic rate, decreased physical activity, and increased lipoprotein lipase activity [18] [19] [20] [21] . Furthermore, fat oxidation might be a critical lipostatic factor that regulates energy balance 22) . It has been reported that fat oxidation per kilogram lean mass was positively correlated with 24-h excretion of nicotine, including that smokers with a high nicotine uptake use more lipids to sustain fasting resting energy expenditure than non-smokers 23) . Therefore, if subjects stop smoking and do not modulate their lipid intake over time, the imbalance in lipid intake and fat oxidation may induce an increase in body fat.
Our study has several limitations. We used a modified NCEP definition with BMI instead of waist circumference. The central pattern of distribution, with its higher weighting of waist circumference, is associated with more insulin resistance than is the peripheral pattern of distribution 24, 25) . Some data show that waist circumference predicts diabetes marginally better than BMI 26, 27) . Nevertheless, most physicians routinely assess BMI, whereas the value of waist measurements in clinical practice has not been thoroughly examined and may require modification for different ethnic groups. A number of investigations have also shown that BMI is as effective as waist circumference for predicting the development of type 2 diabetes and other metabolic disturbances [26] [27] [28] [29] [30] . Moreover, the Japan Society for the Study of Obesity has recently reported that BMI can estimate visceral fat measured by computed tomography as robustly as waist circumference and that obesity-related complications increase for a BMI ≥25 and the best combination of sensitivity and specificity for detecting subjects with multiple risk factors is a BMI of 25 12) . This Society suggests that obesity is adequately specified as a BMI ≥25 in Japan where the prevalence and degree of obesity remained mild.
Second, bias in case-finding could have occurred. Specifically, smokers are more likely to visit a doctor for reasons other than the MS, so that the MS could have been found by chance. However, because all incidental cases were found during periodic annual screening in our study, such a bias is unlikely to have occurred. Furthermore, in this study, the first incidental cases of the MS were used for the analyses. Although these may overestimate the incidence of the MS, the risk of developing the MS is not affected because of the independence of an excessive classification with smoking status.
Finally, we did not assess participants' dietary habits. Dietary lipids, fibers, or carbohydrates may influence fasting insulin levels [31] [32] [33] , and diets with a high glycemic load and a low cereal fiber content may be associated with the risk of the MS 34, 35) . Research is needed to clarify the causal relation between cigarette smoking and the risk of the MS.
Despite these potential limitations, our findings support the conclusion that cigarette smoking is associated with an increased risk of the MS. Because smoking cessation is related to the MS for subsequent body weight gain, health professionals should help patients avoid weight gain.
